Borrelli Eric P, Taneja Ashley, Abdallah Shafiq, Weiss Mia, Wilson Nicole S, Beer Idal, Lucaci Julia D
Health Economics and Outcomes Research, MMS, Becton, Dickinson and Company, San Diego, CA, USA.
HEOR Strategic Planning, Becton, Dickinson and Company, Franklin Lakes, NJ, USA.
Clinicoecon Outcomes Res. 2025 Jul 22;17:507-518. doi: 10.2147/CEOR.S534748. eCollection 2025.
To estimate the economic impact of implementing smart infusion pump interoperability for a hypothetical health system in the United States (US).
An economic model was developed to assess the financial impact of implementing smart infusion pump interoperability with electronic health records (EHRs) for a health system. The model perspective was that of a moderately-large hypothetical US heath-system consisting of 6 hospitals, with 1,500 staffed beds and 50,000 discharges annually. The main outcomes of interest in this model were patient safety and outpatient intravenous (IV) administration charge capture. The impact of interoperability on patient safety was assessed by measuring the estimated reduction in preventable adverse drug events (pADEs). The impact on outpatient charge capture was assessed by estimating the reduction in lost charges due to the implementation of interoperability. All model parameters and inputs were derived and supported by peer-reviewed literature.
In the base-case analysis, the implementation of smart infusion pump interoperability resulted in an annual reduction of 56 pADEs, saving the health system $531,891 in associated pADE treatment costs. This equates to a total reduction of 281 pADEs over the 5-year time-horizon, with a cumulative cost savings of $2,659,457. Additionally, the implementation of interoperability recouped $2,419,673 in outpatient infusion administration charges annually, which is equivalent to $12,098,363 in recouped charges over five years.
The implementation of smart infusion pump interoperability has the potential to enhance patient safety by reducing pADEs and improving outpatient administration charge capture. However, it is important to note that while the model is based on peer-reviewed model inputs, the model itself is theoretical in nature without real-world data validation and does not account for investment costs. Health systems should carefully evaluate the safety and economic implications of smart infusion pump interoperability when deciding whether to invest in this technology.
评估在美国一个假设的医疗系统中实施智能输液泵互操作性的经济影响。
开发了一个经济模型，以评估为一个医疗系统实施智能输液泵与电子健康记录（EHR）互操作性的财务影响。该模型的视角是一个中等规模的假设美国医疗系统，由6家医院组成，每年有1500张配备医护人员的床位和50000例出院病例。该模型关注的主要结果是患者安全和门诊静脉注射（IV）给药费用收取。通过测量可预防的药物不良事件（pADEs）估计减少量来评估互操作性对患者安全的影响。通过估计由于实施互操作性导致的收费损失减少量来评估对门诊收费收取的影响。所有模型参数和输入均来自同行评审文献并得到其支持。
在基础案例分析中，实施智能输液泵互操作性每年减少56例pADEs，为医疗系统节省531891美元的相关pADE治疗成本。这相当于在5年时间范围内总共减少281例pADEs，累计节省成本2659457美元。此外，互操作性的实施每年追回2419673美元的门诊输液给药费用，相当于5年追回费用12098363美元。
实施智能输液泵互操作性有可能通过减少pADEs并改善门诊给药费用收取来提高患者安全。然而，需要注意的是，虽然该模型基于同行评审的模型输入，但模型本身本质上是理论性的，没有经过实际数据验证，也未考虑投资成本。医疗系统在决定是否投资这项技术时，应仔细评估智能输液泵互操作性的安全性和经济影响。
